Mitochondrial DNA mutations in renal disease: an overview

Area of Science:

• Nephrology
• Mitochondrial Biology
• Genetics

Background:

• Kidneys possess high energy demands, necessitating a high density of mitochondria in renal cells.
• Mitochondrial cytopathies arise from mutations in mitochondrial or nuclear DNA, impacting cellular energy production.
• Mitochondrial dysfunction is increasingly recognized as a contributor to diverse renal pathologies.

Purpose of the Study:

• To review the spectrum of renal manifestations associated with mitochondrial cytopathies.
• To highlight the impact of mitochondrial dysfunction on tubular, glomerular, and tubulointerstitial compartments of the kidney.
• To underscore the need for improved understanding of underlying molecular mechanisms for enhanced therapeutic strategies.

Main Methods:

• Literature review of mitochondrial cytopathies and their renal manifestations.
• Analysis of reported cases and pathomechanisms linking mitochondrial dysfunction to kidney diseases.
• Synthesis of current knowledge on renal manifestations including Fanconi Syndrome, nephrotic syndrome, and tubulointerstitial nephritis.

Main Results:

• Mitochondrial dysfunction can manifest as tubular disorders (e.g., Fanconi Syndrome, distal tubulopathies causing hypomagnesemia).
• Glomerular manifestations include nephrotic syndrome, often linked to focal segmental glomerulosclerosis.
• Tubulointerstitial nephritis is another significant manifestation, potentially progressing to end-stage renal disease.

Conclusions:

• Mitochondrial cytopathies present a wide array of renal complications affecting different kidney structures.
• Current therapeutic approaches are primarily supportive due to incomplete understanding of disease mechanisms.
• Further research into the molecular basis of these conditions is essential for advancing treatment options.